Is vitamin D important for preserving cognition? A positive correlation of serum 25-hydroxyvitamin D concentration with cognitive function.

[1]  L. Allen,et al.  Measurement of total vitamin B12 and holotranscobalamin, singly and in combination, in screening for metabolic vitamin B12 deficiency. , 2006, Clinical chemistry.

[2]  Martin Lipkin,et al.  The role of vitamin D in cancer prevention. , 2006, American journal of public health.

[3]  J. Iwamoto,et al.  Amelioration of Osteoporosis and Hypovitaminosis D by Sunlight Exposure in Hospitalized, Elderly Women With Alzheimer's Disease: A Randomized Controlled Trial , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[4]  M. Holick,et al.  Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. , 2005, The Journal of clinical endocrinology and metabolism.

[5]  Bess Dawson-Hughes,et al.  Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. , 2005, JAMA.

[6]  Takashi Morihara,et al.  A Diet Enriched with the Omega-3 Fatty Acid Docosahexaenoic Acid Reduces Amyloid Burden in an Aged Alzheimer Mouse Model , 2005, The Journal of Neuroscience.

[7]  P. Lips,et al.  Estimates of optimal vitamin D status , 2005, Osteoporosis International.

[8]  H. Richter,et al.  25-hydroxyvitamin D, 24, 25-dihydroxyvitamin D and 1,25-dihydroxyvitamin D in human cerebrospinal fluid , 1984, Klinische Wochenschrift.

[9]  C. Polman,et al.  Multiple sclerosis and vitamin D: an update , 2004, European Journal of Clinical Nutrition.

[10]  A. Bava,et al.  Vitamin B12 and folate depletion in cognition: a review. , 2004, Neurology India.

[11]  Bess Dawson-Hughes,et al.  Effect of Vitamin D on falls: a meta-analysis. , 2004, JAMA.

[12]  M. Holick,et al.  Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. , 2004, The American journal of clinical nutrition.

[13]  A. Wittich,et al.  High prevalence of vitamin D insufficiency in healthy elderly people living at home in Argentina , 2004, European Journal of Clinical Nutrition.

[14]  J. Honnorat,et al.  Redifferentiation Therapy in Brain Tumors: Long-lasting Complete Regression of Glioblastomas and an Anaplastic Astrocytoma Under Long Term 1-alpha-hydroxycholecalciferol , 2004, Journal of Neuro-Oncology.

[15]  W. Stumpf,et al.  1,25(OH)2 vitamin D3 sites of action in spinal cord and sensory ganglion , 2004, Anatomy and Embryology.

[16]  R. Yolken,et al.  Low maternal vitamin D as a risk factor for schizophrenia: a pilot study using banked sera , 2003, Schizophrenia Research.

[17]  R. Lew,et al.  Effects of Vitamin D and Calcium Supplementation on Falls: A Randomized Controlled Trial , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[18]  François Berger,et al.  New clues about vitamin D functions in the nervous system , 2002, Trends in Endocrinology & Metabolism.

[19]  Elina Hyppönen,et al.  Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study , 2001, The Lancet.

[20]  B. Hoffer,et al.  Vitamin D3 attenuates 6-hydroxydopamine-induced neurotoxicity in rats , 2001, Brain Research.

[21]  S. Shimohama,et al.  Protective effects of 1α,25-(OH)2D3 against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture , 2001, Neuropharmacology.

[22]  A. Howie,et al.  Extrarenal Expression of 25-Hydroxyvitamin D3-1α-Hydroxylase1 , 2001 .

[23]  Philip W. Landfield,et al.  Vitamin D Hormone Confers Neuroprotection in Parallel with Downregulation of L-Type Calcium Channel Expression in Hippocampal Neurons , 2001, The Journal of Neuroscience.

[24]  K. Wikvall,et al.  Porcine microsomal vitamin D(3) 25-hydroxylase (CYP2D25). Catalytic properties, tissue distribution, and comparison with human CYP2D6. , 2000, The Journal of biological chemistry.

[25]  T. Hayashi,et al.  Vitamin D3 attenuates cortical infarction induced by middle cerebral arterial ligation in rats , 2000, Neuropharmacology.

[26]  R. Heaney,et al.  Vitamin D: How Much Do We Need, and How Much is Too Much? , 2000, Osteoporosis International.

[27]  T. Veenstra,et al.  Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord , 1999, Journal of Chemical Neuroanatomy.

[28]  Yoshihiro Sato,et al.  High prevalence of vitamin D deficiency and reduced bone mass in elderly women with Alzheimer's disease. , 1998, Bone.

[29]  P. Brachet,et al.  1,25‐dihydroxyvitamin D3 regulates the expression of VDR and NGF gene in Schwann cells in vitro , 1998 .

[30]  R. Bouillon,et al.  Vitamin D and regulation of gene expression. , 1998, Current opinion in clinical nutrition and metabolic care.

[31]  P. Brachet,et al.  Expression of inducible nitric oxide synthase during rat brain inflammation: Regulation by 1,25‐dihydroxyvitamin D3 , 1998, Glia.

[32]  W. Miller,et al.  Cloning of human 25-hydroxyvitamin D-1 alpha-hydroxylase and mutations causing vitamin D-dependent rickets type 1. , 1997, Molecular endocrinology.

[33]  P. Brachet,et al.  1,25-Dihydroxyvitamin D3 inhibits the expression of inducible nitric oxide synthase in rat central nervous system during experimental allergic encephalomyelitis. , 1997, Brain research. Molecular brain research.

[34]  P. Galan,et al.  Prevalence of Vitamin D Insufficiency in an Adult Normal Population , 1997, Osteoporosis International.

[35]  P. Brachet,et al.  1,25‐Dihydroxyvitamin D3, an inducer of glial cell line‐derived neurotrophic factor , 1996, Neuroreport.

[36]  T. Dawson,et al.  NITRIC OXIDE ACTIONS IN NEUROCHEMISTRY , 1996, Neurochemistry International.

[37]  P. Brachet,et al.  1,25‐Dihydroxyvitamin D3 regulates NT‐3, NT‐4 but not BDNF mRNA in astrocytes , 1994, Neuroreport.

[38]  A. MacKenzie-Graham,et al.  The Role of Nitric Oxide in Glial Pathology a , 1994, Annals of the New York Academy of Sciences.

[39]  P. Brachet,et al.  1,25-dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells. , 1994, Brain research. Molecular brain research.

[40]  P. Brachet,et al.  Synthesis of 1,25‐dihydroxyvitamin D3 by rat brain macrophages in vitro , 1994, Journal of neuroscience research.

[41]  S. Carswell,et al.  Chronic 1,25-dihydroxyvitamin D3-mediated induction of nerve growth factor mRNA and protein in L929 fibroblasts and in adult rat brain , 1994, Brain Research.

[42]  P. Brachet,et al.  Expression of 25(OH) vitamin D3 24-hydroxylase gene in glial cells. , 1993, Neuroreport.

[43]  M. Somerville,et al.  Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels. , 1992, Brain research. Molecular brain research.

[44]  R. Houlgatte,et al.  1,25‐Dihydroxyvitamin D3 is a potent inducer of nerve growth factor synthesis , 1991, Journal of neuroscience research.

[45]  S. Krane,et al.  Metabolic Bone Disease and Clinically Related Disorders , 1990 .

[46]  K. Haglid,et al.  Parvalbumin increases in the caudate putamen of rats with vitamin D hypervitaminosis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[47]  M. Haussler,et al.  Immunocytochemical localization of the 1,25-dihydroxyvitamin D3 receptor in target cells. , 1988, Endocrinology.

[48]  V. Luine,et al.  1,25-Dihydroxyvitamin D3 treatment results in increased choline acetyltransferase activity in specific brain nuclei. , 1986, Endocrinology.

[49]  H. DeLuca,et al.  Brain target sites for 1,25-dihydroxyvitamin D3. , 1982, Science.

[50]  H. DeLuca,et al.  Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. , 1979, Science.

[51]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[52]  C. Christiansen,et al.  “Anticonvulsant Action” of Vitamin D in Epileptic Patients? A Controlled Pilot Study , 1974, British medical journal.

[53]  Burton S. Rosner,et al.  Neuropharmacology , 1958, Nature.